Abstract:
Chronic diseases including cardiovascular, diabetes and cancer persist for a long time in the course of
treatment affecting health and are currently the cause of many deaths. In most cases, the treatment of
chronic infectious diseases especially Tuberculosis relies on conventional drugs which are currently
becoming fruitless due to drug resistance and unpredicted complications in course of treatment.
However, herbal medicines have for a long time been used in prevention and treatment of chronic diseases
including asthma and heart diseases in Africa. In this study, we extracted metabolites and screened
for active compounds with potential free radical scavenging and pharmacological activities from Bersama
abyssinica, the plant commonly used in traditional medicine in Tanzania. B. abyssinica root, stembark and
leaf were air dried, sequentially extracted in various solvents including petroleum ether, dichloromethane,
ethylacetate and methanol to yield extracts and fractions. The extracts and fractions were
tested for the presence of several metabolites and antioxidant activity. The analysis of chemical compounds
from resultant extracts was done by GC–MS for non-polar factions and LC-MS/MC for moderate
polar extracts.High amount of phenolic acid, flavonoids and tannin were identified in ethylacetate fraction
compared to ethanol, dichloromethane and petroleum ether. The GC–MS analysis of petroleum ether
extract of B. abyssinica stem back yielded twelve (12) compounds with varying composition. The most
abundant compounds were 2-Butenoic acid, 3-methyl-, ethyl ester comprising 33.8%, n-Hexadecanoic
acid comprising 16.7% and Ethanolpentamethyl- yielded in 16.7%.The LC-MS/MS analysis of Ethyl acetate
fractions yielded 20 compounds including; Mangiferin and Isoquercitin were abundant in leaves, stembark
and roots. Lastly, ethyl vanillate was identified in both roots and leaves whereas Quercitrin and
7,8-Dimethoxycoumarin were found in stembark and root.These findings indicated that B. abyssinica is
rich in phenolic compounds ranging from phenolic acids, flavonoids and coumarin that possess high
antioxidant and pharmacological properties potential for treatment of chronic diseases.
2022 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).